AKT1 and cancer: Another prominent class of PI3K inhibitors is the dual PI3K/mTOR inhibitors, which have been regarded as a highly promising drug class due to the sheer importance of the PI3K/AKT/mTOR signaling axis in cancer biology [141,153].